Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Downgrades Galmed Pharmaceuticals to Neutral

HC Wainwright & Co. analyst Ed Arce downgrades Galmed Pharmaceuticals (NASDAQ:GLMD) from Buy to Neutral.
byBenzinga Newsdesk
May 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Ed Arce downgrades Galmed Pharmaceuticals (NASDAQ:GLMD) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0